SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-20-000494
Filing Date
2020-05-20
Accepted
2020-05-20 20:40:11
Documents
2
Period of Report
2020-05-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1617
2 EX-24 lucchese_poa.htm EX-24 5174
  Complete submission text file 0000905718-20-000494.txt   8338
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TIMBER PHARMACEUTICALS, INC. 900 E. HAMILTON AVENUE, SUITE 100 CAMPBELL CA 95008
Business Address
Lucchese Joseph (Reporting) CIK: 0001810134 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37411 | Film No.: 20899725